EUVIMEDEUVIMED entdecken
Open Access

Association between weight change and risk of liver fibrosis in adults with type 2 diabetes

Pan Ke, Minzhi Xu, Jie Feng, Qingfeng Tian, Yan He, Kai Lu, Zuxun Lu

Journal of Global Health · 2023

DOI: 10.7189/jogh.13.04138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Global Health, 2023. Verfasst von Pan Ke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver fibrosis plays a key role in the progression of non-alcoholic fatty liver disease to cirrhosis. Considering weight change is known to be closely associated with increased risk of liver fibrosis, we aimed to address a gap in evidence regarding the existence of this association in patients with type 2 diabetes (T2D).

Methods

We included data on 622 T2D patients and 1618 non-T2D participants from the 2017-2018 cycle of the National Health and Nutrition Examination Survey (NHANES). We assessed liver fibrosis by the median values of liver stiffness measurement (LSM). According to the participants' body mass index (BMI) at age 25 (early adulthood), 10 years prior (middle adulthood), and at the 2017-2018 cycle (late adulthood), we categorised weight change patterns into stable non-obese, weight loss, weight gain, and stable obese. We applied logistic regression to association analysis and used population attributable fraction (PAF) to analyses hypothetical prevention regimens.

Results

The prevalence of liver fibrosis was higher in T2D patients (23.04%) than in non-T2D participants (6.70%), while weight change was associated with a greater risk of fibrosis in the former compared to the latter group. Compared with T2D patients in the stable non-obese group, stable obese individuals from 10 years prior to the 2017-2018 cycle had the highest risk of developing liver fibrosis, corresponding to an adjusted odds ratio (aOR) of 3.13 (95% confidence interval = 1.84-5.48). Absolute weight change patterns showed that the risk of liver fibrosis was highest (aOR = 2.94) when T2D patients gained at least 20 kg of weight from 10 years prior to 2017-2018 cycle.

Conclusions

Obesity in middle and late adulthood is associated with an increased risk of T2D complicated with liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseHumansAdultNutrition SurveysLiver CirrhosisObesity

Autor:innen und Institutionen

  • Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • School of Public Health, Zhengzhou University, Zhengzhou, Henan, China.
  • Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Zitieren

APA

Ke, P., Xu, M., Feng, J., Tian, Q., He, Y., Lu, K., & Lu, Z. (2023). Association between weight change and risk of liver fibrosis in adults with type 2 diabetes. Journal of Global Health. https://doi.org/10.7189/jogh.13.04138

Vancouver

Ke P, Xu M, Feng J, Tian Q, He Y, Lu K, et al. Association between weight change and risk of liver fibrosis in adults with type 2 diabetes. Journal of Global Health. 2023. doi:10.7189/jogh.13.04138

BibTeX
@article{Ke2023,
  author = {Ke, Pan and Xu, Minzhi and Feng, Jie and Tian, Qingfeng and He, Yan and Lu, Kai and Lu, Zuxun},
  title = {Association between weight change and risk of liver fibrosis in adults with type 2 diabetes},
  journal = {Journal of Global Health},
  year = {2023},
  doi = {10.7189/jogh.13.04138}
}
Kostenlos starten →